Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.96 |
| ▸ | PPARG | P37231 | 2/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | GRM2 | Q14416 | 5/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.41 |
| ▸ | PRKCA | P17252 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1358227 | 1.00 | CYP1A2 (0.96) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL28537693 | 1.00 | CYP1A2 (0.96) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL112484 | 1.00 | CYP1A2 (0.96) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL2077607 | 0.98 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL7054931 | 0.98 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL7059195 | 0.98 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL3661965 | 0.98 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL333202 | 0.98 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL7059128 | 0.98 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 | |
| SCHEMBL17627672 | 0.98 | CYP1A2 (1.00) | CYP1A2PPARGEPHX1ALDH1A1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4514477-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | Firmenich SA (CH) | 2025-03-05 | — | — | EP | claimed |
| CN-119486703-A | Fragrance composition with lasting fragrance appearance | 弗门尼舍有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-116018124-A | Composition for limiting or eliminating sweat odor perception | 弗门尼舍有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-120142505-A | Application of hydroxyapatite in pretreatment of fruit juice, sample pretreatment method and detection method of lactone compound in fruit juice | 广州市名花香料有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-119789844-A | Fragrance composition containing 2, 3-butanediol and/or 1, 3-butanediol | 弗门尼舍有限公司 | 2025-04-08 | — | — | CN | disclosed |
| EP-4514477-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | Firmenich SA (CH) | 2025-03-05 | — | — | EP | disclosed |
| CN-119486703-A | Fragrance composition with lasting fragrance appearance | 弗门尼舍有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20240350381-A1 | FRAGRANCES WITH IMPROVED LONG-LASTING PERFORMANCE | FIRMENICH SA (CH) | 2024-10-24 | — | — | US | disclosed |
| EP-3630055-B1 | AQUEOUS MICROEMULSION | FIRMENICH & CIE (CH) | 2024-07-31 | — | — | EP | disclosed |
| EP-4338761-A1 | PERFUMING COMPOSITIONS | Firmenich SA (CH) | 2024-03-20 | — | — | EP | disclosed |
| EP-4223928-A1 | WALLPAPER COMPOSITION AND WALLPAPER EMITTING AROMATIC COMPONENT BY HEAT | KT & G Corporation (KR) | 2023-08-09 | — | — | EP | disclosed |
| CN-116018124-A | Composition for limiting or eliminating sweat odor perception | 弗门尼舍有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-110709056-B | Aqueous microemulsion | 弗门尼舍有限公司 | 2022-12-13 | — | — | CN | disclosed |
| US-11504310-B2 | Aqueous microemulsion | FIRMENICH SA (CH) | 2022-11-22 | — | — | US | disclosed |
| CN-108484537-A | A kind of preparation method of (R)-(+)-nonyl lactone and (S)-(-)-nonyl lactone | 博润生物科技南通有限公司 | 2018-09-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240350381-A1 | FRAGRANCES WITH IMPROVED LONG-LASTING PERFORMANCE | FABP5, FAAH2, FASN | CYP1A2 462/4885PPARG 638/4885EPHX1 2380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.